Bill Search

  1. Introduced 2020-02-12
  2. Passed House 2020-02-21
  3. Passed Senate 2020-03-02
  4. Signed into Law
HJM 13
Idaho House Bill
Bill Title:
HEALTH – Stating findings of the Legislature and requesting that Congress take action necessary to make buprenorphine more accessible to patients.
Last Action:
2020-03-09, House: Delivered to Secretary of State at 10:19 a.m. on March 6, 2020
Latest bill text:
Bill Text

Do you support this bill?

Official Summary/Bill Text

Comments on Bill





2020-03-09, House
  • Delivered to Secretary of State at 10:19 a.m. on March 6, 2020
2020-03-06, House
  • Returned Signed by the President; Ordered Transmitted to Secretary of State
2020-03-05, Senate
  • Received from the House enrolled/signed by Speaker
  • Signed by President; returned to House
2020-03-04, House
  • Reported Enrolled; Signed by Speaker; Transmitted to Senate
2020-03-03, House
  • Returned from Senate Passed; to JRA for Enrolling
2020-03-02, Senate
  • Read in full – ADOPTED – voice voteFloor Sponsor – HeiderTitle apvd – to House
2020-02-27, Senate
  • Reported out of Committee with Do Pass Recommendation; to 10th order; held one legislative day
2020-02-24, Senate
  • Received from the House passed; filed for first reading
  • Introduced, read first time; referred to: Health & Welfare
2020-02-21, House
  • Read Third Time in Full – ADOPTED – voice voteFloor Sponsor – EllisTitle apvd – to Senate
2020-02-20, House
  • U.C. to hold place on third reading calendar one legislative day
2020-02-19, House
  • Read second time; Filed for Third Reading
2020-02-18, House
  • Reported out of Committee with Do Pass Recommendation, Filed for Second Reading
2020-02-13, House
  • Reported Printed and Referred to Health & Welfare
2020-02-12, House
  • Introduced, read first time, referred to JRA for Printing

Bill Texts